YSB (HKSE:09885) Equity-to-Asset : 0.37 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is YSB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. YSB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$2,100 Mil. YSB's Total Assets for the quarter that ended in Dec. 2023 was HK$5,701 Mil. Therefore, YSB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.37.

The historical rank and industry rank for YSB's Equity-to-Asset or its related term are showing as below:

HKSE:09885' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.06 Med: -0.9 Max: 0.37
Current: 0.37

During the past 4 years, the highest Equity to Asset Ratio of YSB was 0.37. The lowest was -1.06. And the median was -0.90.

HKSE:09885's Equity-to-Asset is ranked worse than
60.73% of 685 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs HKSE:09885: 0.37

YSB Equity-to-Asset Historical Data

The historical data trend for YSB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Equity-to-Asset Chart

YSB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

-0.95

-0.84

-1.06

0.37

YSB Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			-0.84	-	-1.06	0.38	0.37

Competitive Comparison of YSB's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, YSB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where YSB's Equity-to-Asset falls into.

YSB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

YSB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2099.795	/	5700.604
	=	0.37

YSB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2099.795	/	5700.604
	=	0.37

YSB (HKSE:09885) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

YSB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of YSB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB (HKSE:09885) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines